Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Deloitte
Novartis
Harvard Business School
Farmers Insurance
Cantor Fitzgerald
Accenture
Julphar
Cipla
Queensland Health

Generated: February 19, 2018

DrugPatentWatch Database Preview

TYLENOL W/ CODEINE NO. 4 Drug Profile

« Back to Dashboard

Which patents cover Tylenol W/ Codeine No. 4, and what generic alternatives are available?

Tylenol W/ Codeine No. 4 is a drug marketed by Ortho Mcneil Pharm and Janssen Pharms and is included in two NDAs.

The generic ingredient in TYLENOL W/ CODEINE NO. 4 is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.
Drug patent expirations by year for TYLENOL W/ CODEINE NO. 4
Pharmacology for TYLENOL W/ CODEINE NO. 4
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

US Patents and Regulatory Information for TYLENOL W/ CODEINE NO. 4

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ortho Mcneil Pharm TYLENOL W/ CODEINE NO. 4 acetaminophen; codeine phosphate CAPSULE;ORAL 087421-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Janssen Pharms TYLENOL W/ CODEINE NO. 4 acetaminophen; codeine phosphate TABLET;ORAL 085055-004 Approved Prior to Jan 1, 1982 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Chubb
Healthtrust
Teva
AstraZeneca
Colorcon
Johnson and Johnson
Deloitte
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot